| Name | Olsson's Pharmacy |
|---|---|
| Organization Name | Tonaire Corporation |
| Location | 576 Lafayette Ave, Hawthorne, New Jersey 07506 |
| Type | Community/Retail Pharmacy |
| Phone | (973) 427-1700 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Tiny, biodegradable particles filled with medicine may also contain answers to some of the biggest human health problems, including cancer and tuberculosis.
Diabetes mellitus (DM) is probably one of the oldest known diseases and the incidence has been increasing steadily all over the world. This metabolic disease is characterized by chronic hyperglycemia due to defect in insulin secretion and/or insulin action.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that in the Phase 3 VIVID-DME and VISTA-DME trials of EYLEA (aflibercept) Injection for the treatment of diabetic macular edema, EYLEA 2 milligrams (mg) dosed monthly and EYLEA 2 mg dosed every two months (after 5 initial monthly injections) achieved the primary endpoint of a significantly greater improvement in best-corrected visual acuity from baseline compared to laser photocoagulation at 52 weeks.
A research team led by University of South Florida neuroscientist Huntington Potter, PhD, CEO of the Johnnie B. Byrd Sr. Alzheimer's Center & Research Institute, for the first time has defined how the protein Apolipoprotein E (ApoE) contributes to both the formation of amyloid brain lesions and the memory loss associated with Alzheimer's disease.
› Verified 6 days ago
| NPI Number | 1245339449 |
| Organization Name | TONAIRE CORPORATION |
| Doing Business As | OLSSON'S PHARMACY |
| Type | Community/Retail Pharmacy |
| Address | 576 Lafayette Avenue, Hawthorne, NJ 07506 |
| Phone Number | 973-427-1700 |
News Archive
Tiny, biodegradable particles filled with medicine may also contain answers to some of the biggest human health problems, including cancer and tuberculosis.
Diabetes mellitus (DM) is probably one of the oldest known diseases and the incidence has been increasing steadily all over the world. This metabolic disease is characterized by chronic hyperglycemia due to defect in insulin secretion and/or insulin action.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that in the Phase 3 VIVID-DME and VISTA-DME trials of EYLEA (aflibercept) Injection for the treatment of diabetic macular edema, EYLEA 2 milligrams (mg) dosed monthly and EYLEA 2 mg dosed every two months (after 5 initial monthly injections) achieved the primary endpoint of a significantly greater improvement in best-corrected visual acuity from baseline compared to laser photocoagulation at 52 weeks.
A research team led by University of South Florida neuroscientist Huntington Potter, PhD, CEO of the Johnnie B. Byrd Sr. Alzheimer's Center & Research Institute, for the first time has defined how the protein Apolipoprotein E (ApoE) contributes to both the formation of amyloid brain lesions and the memory loss associated with Alzheimer's disease.
› Verified 6 days ago
News Archive
Tiny, biodegradable particles filled with medicine may also contain answers to some of the biggest human health problems, including cancer and tuberculosis.
Diabetes mellitus (DM) is probably one of the oldest known diseases and the incidence has been increasing steadily all over the world. This metabolic disease is characterized by chronic hyperglycemia due to defect in insulin secretion and/or insulin action.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that in the Phase 3 VIVID-DME and VISTA-DME trials of EYLEA (aflibercept) Injection for the treatment of diabetic macular edema, EYLEA 2 milligrams (mg) dosed monthly and EYLEA 2 mg dosed every two months (after 5 initial monthly injections) achieved the primary endpoint of a significantly greater improvement in best-corrected visual acuity from baseline compared to laser photocoagulation at 52 weeks.
A research team led by University of South Florida neuroscientist Huntington Potter, PhD, CEO of the Johnnie B. Byrd Sr. Alzheimer's Center & Research Institute, for the first time has defined how the protein Apolipoprotein E (ApoE) contributes to both the formation of amyloid brain lesions and the memory loss associated with Alzheimer's disease.
› Verified 6 days ago
Mcb Dme Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 290 Lafayette Ave, Hawthorne, New Jersey 07506 Phone: (973) 553-0777 | |
Melcon Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 207 Diamond Bridge Ave, Hawthorne, New Jersey 07506 Phone: (973) 427-1234 | |
Olsson's Pharmacy Type: Community/Retail Pharmacy Location: 576 Lafayette Ave, Hawthorne, New Jersey 07506 Phone: (973) 427-1700 | |
Walgreens #18306 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 325 Lafayette Ave, Hawthorne, New Jersey 07506 Phone: (973) 423-5500 | |
Wilpage Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 146 Genevieve Ave, Hawthorne, New Jersey 07506 Phone: (973) 423-4100 |